Sabra Competitors

Stocks Germany . 
Stock . Sabra Health Care
SBC Stock  EUR 17.45  0.05  0.29%   
Sabra Health Care competes with Infrastrutture Wireless, TITANIUM TRANSPORTGROUP, KAUFMAN ET, TRAINLINE PLC, and Transport International; as well as few others. The company classifies itself under Real Estate sector and is part of REIT - Healthcare Facilities industry. Analyzing Sabra Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Sabra Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Sabra Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Sabra Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
15.6517.4519.25
Details
Intrinsic
Valuation
LowRealHigh
12.5514.3519.20
Details

Sabra Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sabra Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Sabra and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sabra Health Care does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
KWO
+ 0.7
47X
KWO
+ 0.68
3GH
2T9A
+ 0.55
I9V
3GH
+ 0.5
47X
2T9A
+ 0.4
3GH
M7O
+ 0.31
47X
  
High negative correlations   
2T9A
- 0.91
WI8
I9V
- 0.61
WI8
3GH
- 0.27
WI8
M7O
- 0.2
I9V
KWO
- 0.19
WI8
ODP
- 0.0
KWO

Risk-Adjusted Indicators

There is a big difference between Sabra Stock performing well and Sabra Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sabra Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Sabra Health Competitive Analysis

The better you understand Sabra Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sabra Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sabra Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SBC 47X WI8 I9V 3GH 2T9A M7O KWO ODP
 0.29 
 17.45 
Sabra
 1.41 
 0.72 
CENTURIA
 1.92 
 9.56 
Infrastrutture
 2.44 
 1.68 
TITANIUM
 1.71 
 32.65 
KAUFMAN
 0.41 
 4.80 
TRAINLINE
 4.26 
 0.45 
MTI
 0.00 
 0.95 
Transport
 0.00 
 19.20 
OFFICE
Market Volatility
(90 Days Market Risk)
Not too volatile
Very risky
Not too volatile
Risky
Very steady
Slightly risky
Abnormally volatile
Dangerous
Very steady
Market Performance
(90 Days Performance)
Good
Insignificant
Very Weak
Good
Insignificant
Solid
Insignificant
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Average
About Average
Low
Low
Low
Below Average
About Average
Quite High
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Sell
Buy
Strong Sell
Strong Sell
Strong Hold
Current Ratio
5.91
N/A
0.65
N/A
N/A
1.2
N/A
2.2
N/A
Net Asset
5.75 B
N/A
9.36 B
N/A
1.47 B
N/A
N/A
19.95 B
4.87 B
Profit Margin
-0.15
N/A
0.31
N/A
N/A
0.0316
N/A
0.0193
N/A
EBITDA
216.89 M
N/A
698.41 M
N/A
91.32 M
23.84 M
N/A
286.44 M
405 M
Operating Margin
0.27
N/A
0.48
N/A
N/A
0.0549
N/A
-0.0588
N/A
Current Valuation
5.1 B
N/A
13.3 B
N/A
573.28 M
N/A
N/A
894.76 M
2.38 B
Price To Book
0.9
N/A
2.05
N/A
2.66
N/A
N/A
0.33
0.69
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.92
N/A
Beta
1.29
N/A
0.35
N/A
N/A
1.71
N/A
0.44
N/A
Number Of Employees
42
N/A
246
1.1 K
N/A
750
N/A
13 K
40
Shares Outstanding
231.16 M
N/A
959.91 M
N/A
N/A
480.68 M
N/A
474.94 M
N/A
Cash Flow From Operations
315.73 M
N/A
217.82 M
N/A
92.29 M
(62.08 M)
N/A
1.32 B
346 M
Annual Yield
0.0917
N/A
0.0313
N/A
0.0867
N/A
0.0505
0.0469
0.0503
Total Debt
2.31 B
N/A
3.02 B
N/A
149.39 M
249.43 M
N/A
2.14 B
193 M
Return On Equity
-0.0241
N/A
0.0586
N/A
N/A
0.0321
N/A
0.0099
N/A
Z Score
0.6
N/A
1.8
N/A
3.0
3.6
N/A
N/A
6.4
Return On Asset
0.0155
N/A
0.027
N/A
N/A
0.0149
N/A
-0.0126
N/A
Book Value Per Share
13.23
N/A
4.57
N/A
N/A
0.58
N/A
27.67
N/A
Total Asset
5.75 B
N/A
9.36 B
N/A
1.47 B
N/A
N/A
19.95 B
4.87 B
Debt To Equity
106.6
N/A
57.7
N/A
N/A
0.74
N/A
26.1
N/A
Target Price
19.14
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
1.2
N/A
0.32
N/A
2.5
N/A
N/A
0.5
0.025
Shares Owned By Institutions
90.4
N/A
19.72
N/A
N/A
79.97
N/A
9.16
N/A
Market Capitalization
2.59 B
N/A
9.94 B
N/A
774.07 M
1.55 B
N/A
639.06 M
1.75 B
Price To Earning
25.24
N/A
37.41
N/A
N/A
N/A
N/A
6.26
N/A
Price To Earnings To Growth
N/A
N/A
1.59
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
6.7
N/A
10.75
N/A
0.46
N/A
N/A
0.0917
0.12
Net Income
(77.61 M)
N/A
191.4 M
N/A
43.87 M
(30.49 M)
N/A
245.04 M
(208 M)
Earnings Per Share
-0.33
N/A
0.26
N/A
N/A
0.02
N/A
0.03
N/A
Shares Owned By Insiders
1.35
N/A
67.36
N/A
N/A
0.9
N/A
55.1
N/A
Revenue
624.81 M
N/A
785.15 M
N/A
1.28 B
275.8 M
N/A
7.2 B
8.46 B
Cash And Equivalents
56.81 M
N/A
144.86 M
N/A
N/A
88.72 M
N/A
149.98 M
N/A
Cash Per Share
0.32
N/A
0.24
N/A
N/A
0.19
N/A
0.35
N/A
Gross Profit
372.8 M
N/A
723.21 M
N/A
N/A
152.8 M
N/A
1.84 B
N/A
Day Typical Price
17.45
0.72
9.52
1.68
32.65
4.8
0.45
0.95
19.2
Accumulation Distribution
N/A
0.0139
0.0249
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
0.01
0.24
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
9.2 T
1.0
0.75
9.2 T
9.2 T
(9,223,372,036,855)
(9,223,372,036,855)
0.0
0.0
Period Momentum Indicator
0.05
0.01
0.18
0.04
0.55
(0.02)
(0.02)
N/A
N/A
Rate Of Daily Change
1.0
1.01
1.02
1.02
1.02
1.0
0.96
1.0
1.0
Day Median Price
17.45
0.72
9.5
1.68
32.65
4.8
0.45
0.95
19.2
Price Action Indicator
0.025
0.01
0.15
0.02
0.27
(0.01)
(0.01)
N/A
N/A
Coefficient Of Variation
547.92
1503.96
(573.35)
635.62
2272.26
480.95
2041.08
3844.7
N/A
Mean Deviation
1.33
1.17
0.7292
1.55
1.29
1.44
1.91
1.06
N/A
Jensen Alpha
0.3442
0.0306
(0.16)
0.3502
0.046
0.434
0.1561
0.0767
N/A
Total Risk Alpha
0.0392
(0.14)
(0.34)
(0.01)
(0.21)
0.1139
(0.34)
(0.27)
N/A
Sortino Ratio
0.1047
(0.02)
N/A
0.1005
(0.03)
0.1715
0.0051
(0.03)
N/A
Downside Variance
3.65
3.11
N/A
3.12
2.46
4.41
20.69
8.6
N/A
Standard Deviation
1.8
1.46
1.01
1.94
1.82
2.35
3.1
1.99
N/A
Kurtosis
0.7514
(0.70)
1.58
(0.15)
5.34
7.06
3.51
6.18
N/A
Potential Upside
3.45
2.74
1.12
4.0
2.72
4.52
4.26
4.08
N/A
Treynor Ratio
(1.49)
0.1828
0.9473
(0.65)
0.346
1.27
(1.18)
(0.14)
N/A
Maximum Drawdown
8.26
5.68
4.56
6.98
11.08
15.43
20.72
15.06
N/A
Variance
3.24
2.13
1.01
3.78
3.31
5.53
9.6
3.96
N/A
Market Risk Adjusted Performance
(1.48)
0.1928
0.9573
(0.64)
0.356
1.28
(1.17)
(0.13)
N/A
Risk Adjusted Performance
0.1452
0.0556
(0.13)
0.1263
0.0394
0.1657
0.045
0.026
N/A
Skewness
(0.31)
(0.01)
(0.82)
0.4667
1.24
1.71
0.1238
0.0499
N/A
Semi Deviation
1.58
1.19
N/A
1.41
1.47
1.27
2.45
1.55
N/A
Information Ratio
0.1111
(0.02)
(0.30)
0.0912
(0.03)
0.1532
0.0075
(0.04)
N/A
Value At Risk
(3.09)
(2.56)
(2.36)
(2.13)
(2.82)
(2.01)
(6.00)
(3.06)
N/A
Expected Short fall
(1.45)
(1.70)
N/A
(1.96)
(1.50)
(2.07)
(3.65)
(2.24)
N/A
Downside Deviation
1.91
1.76
N/A
1.77
1.57
2.1
4.55
2.93
N/A
Semi Variance
2.5
1.42
N/A
1.98
2.17
1.6
6.01
2.4
N/A

Sabra Health Competition Performance Charts

Five steps to successful analysis of Sabra Health Competition

Sabra Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sabra Health Care in relation to its competition. Sabra Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Sabra Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sabra Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sabra Health Care, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Sabra Health position

In addition to having Sabra Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Blend Funds Thematic Idea Now

Large Blend Funds
Large Blend Funds Theme
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Sabra Stock

Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY